Loading...
SDA is not a good buy right now. The technical setup is bearish (downtrend by moving averages, negative MACD), there are no proprietary buy signals (AI Stock Picker/SwingMax), no supportive news catalysts, and pattern-based forward odds point to modest downside over the next day/week/month. For an impatient buyer, the current risk/reward is unfavorable—avoid buying here.
Trend/structure: Bearish alignment with SMA_200 > SMA_20 > SMA_5, implying the stock remains in a broader downtrend. Momentum: MACD histogram is negative (-0.0129) and negatively contracting—still bearish momentum, though selling pressure may be easing. RSI: RSI(6) at ~39 is neutral-to-weak (not oversold), suggesting no strong mean-reversion buy signal yet. Levels: Pivot 2.033. Immediate support S1 1.966 then S2 1.925; resistance R1 2.10 then R2 2.141. At 1.99, price is sitting just above support, but not showing a confirmed reversal. Quant/pattern outlook: Similar-pattern analysis indicates ~70% probability of -0.73% next day, -2.8% next week, -3.35% next month—bearish skew.
Intellectia Proprietary Trading Signals Intellectia Proprietary Trading Signals
Gross margin improved YoY (54.38%, +2.08% YoY), and revenue grew modestly in 2025/Q3 (+5.61% YoY). Hedge fund and insider activity are reported as neutral (no notable selling pressure from these groups in the provided data).
No news catalysts in the last week to drive a re-rating. Technical trend remains bearish (SMA stack + negative MACD). Pattern-based forward projection is biased to downside over the next day/week/month. Profitability deteriorated sharply YoY (net income down -95.79% YoY to a small loss; EPS down to 0). No recent congress trading data and no notable influential-figure activity provided to suggest a sentiment tailwind.
Latest quarter: 2025/Q3. Revenue increased to 115,775,000 (+5.61% YoY), showing modest top-line growth. However, net income fell to -91,000 (-95.79% YoY) and EPS dropped to 0 (-100% YoY), indicating weakening profitability/earnings power. Gross margin improved to 54.38% (+2.08% YoY), which is a positive operational datapoint but has not translated into bottom-line growth in this quarter.
No analyst rating/price target change data was provided, so there is no observable recent trend in Wall Street upgrades/downgrades or target revisions. Pros view (based on available data): improving gross margin and modest revenue growth. Cons view: sharp YoY deterioration in net income/EPS and a clearly bearish technical trend without confirming buy signals.